Evidence map›Paper›PMID 35585227›Full record

ArticleNature reviews. Neurology2022

Author Correction: Why won't it stop? The dynamics of benzodiazepine resistance in status epilepticus.

Richard J Burman, Richard E Rosch, Jo M Wilmshurst, Arjune Sen, Georgia Ramantani, Colin J Akerman, Joseph V Raimondo

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature reviews. Neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Richard J BurmanDepartment of Pharmacology, University of Oxford, Oxford, UK. richard.burman@ndcn.ox.ac.uk.ORCID http://orcid.org/0000-0003-3107-7871
Richard E RoschDepartment of Neuropediatrics, University Children's Hospital Zürich, Zürich, Switzerland.ORCID http://orcid.org/0000-0002-0316-5818
Jo M WilmshurstDepartment of Paediatric Neurology, Red Cross War Memorial Children's Hospital, Cape Town, South Africa.
Arjune SenOxford Epilepsy Research Group, NIHR Biomedical Research Centre, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-8948-4763
Georgia RamantaniDepartment of Neuropediatrics, University Children's Hospital Zürich, Zürich, Switzerland.ORCID http://orcid.org/0000-0002-7931-2327
Colin J AkermanDepartment of Pharmacology, University of Oxford, Oxford, UK.
Joseph V RaimondoNeuroscience Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. joseph.raimondo@uct.ac.za.ORCID http://orcid.org/0000-0002-8266-3128
University of Oxford · GBUniversity of Cape Town · ZAKing's College London · GBUniversity Children's Hospital Zurich · CH

Funding

Wellcome Trust 209164/Z/17/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35585227
OpenAlexW4280564883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.